In-vitro Toxicology Testing Market Share, Growth Analysis 2032

In-vitro Toxicology Testing Market - Product and Services (Consumables, Assays, Equipment, Software), Endpoint and Test (Genotoxicity, Cytotoxicity), Technology (Toxigenomics, Cell Culture), Method (Ex Vivo, In Silico), Industry – Global Forecast, 2024 - 2032

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market scope &amp; definitions

1.2&nbsp;&nbsp;&nbsp; Base estimates &amp; calculations

1.3&nbsp;&nbsp;&nbsp; Data collection

1.4&nbsp;&nbsp;&nbsp; Forecast calculations

1.5&nbsp;&nbsp;&nbsp; Data validation

1.6&nbsp;&nbsp;&nbsp; Data sources

1.6.1&nbsp;&nbsp;&nbsp; Primary

1.6.2&nbsp;&nbsp;&nbsp; Secondary

1.6.2.1&nbsp;&nbsp;&nbsp;Paid sources

1.6.2.2&nbsp;&nbsp;&nbsp;Unpaid sources

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; Industry 3600&nbsp;synopsis

Chapter 3&nbsp;&nbsp;&nbsp;Industry Insights

3.1&nbsp;&nbsp;&nbsp; Industry ecosystem analysis

3.2&nbsp;&nbsp;&nbsp; Industry impact forces

3.2.1&nbsp;&nbsp;&nbsp; Growth drivers

3.2.1.1&nbsp;&nbsp;&nbsp;Rise in government funding for toxicology research

3.2.1.2&nbsp;&nbsp;&nbsp;Increased R&amp;D investments

3.2.1.3&nbsp;&nbsp;&nbsp;Technological advancements

3.2.1.4&nbsp;&nbsp;&nbsp;Growing resistance against animal testing

3.2.2&nbsp;&nbsp;&nbsp; Industry pitfalls &amp; challenges

3.2.2.1&nbsp;&nbsp;&nbsp;Stringent regulatory restrictions

3.2.2.2&nbsp;&nbsp;&nbsp;Lack of in-vitro models to study complex end-points

3.3&nbsp;&nbsp;&nbsp; Growth potential analysis

3.4&nbsp;&nbsp;&nbsp; Technological landscape

3.5&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.5.1&nbsp;&nbsp;&nbsp; Supplier power

3.5.2&nbsp;&nbsp;&nbsp; Buyer power

3.5.3&nbsp;&nbsp;&nbsp; Threat of new entrants

3.5.4&nbsp;&nbsp;&nbsp; Threat of substitutes

3.5.5&nbsp;&nbsp;&nbsp; Industry rivalry

3.6&nbsp;&nbsp;&nbsp; PESTEL analysis

Chapter 4&nbsp;&nbsp;&nbsp;Competitive Landscape, 2023

4.1&nbsp;&nbsp;&nbsp; Introduction

4.2&nbsp;&nbsp;&nbsp; Company matrix analysis

4.3&nbsp;&nbsp;&nbsp; Company market share analysis

4.4&nbsp;&nbsp;&nbsp; Competitive positioning matrix

4.5&nbsp;&nbsp;&nbsp; Strategy dashboard

Chapter 5&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Product and Services, 2018 &ndash; 2032 ($ Mn)

5.1&nbsp;&nbsp;&nbsp; Key trends

5.2&nbsp;&nbsp;&nbsp; Consumables

5.3&nbsp;&nbsp;&nbsp; Assays

5.3.1&nbsp;&nbsp;&nbsp; Bacterial toxicity assays

5.3.2&nbsp;&nbsp;&nbsp; Enzyme toxicity assays

5.3.3&nbsp;&nbsp;&nbsp; Cell-based ELISA and western blots

5.3.4&nbsp;&nbsp;&nbsp; Receptor binding assays

5.3.5&nbsp;&nbsp;&nbsp; Tissue culture assays

5.3.6&nbsp;&nbsp;&nbsp; Others assays

5.4&nbsp;&nbsp;&nbsp; Equipment

5.5&nbsp;&nbsp;&nbsp; Software

5.6&nbsp;&nbsp;&nbsp; Services

Chapter 6&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Endpoint and Test, 2018 &ndash; 2032 ($ Mn)

6.1&nbsp;&nbsp;&nbsp; Key trends

6.2&nbsp;&nbsp;&nbsp; Absorption, distribution, metabolism, and excretion (ADME)

6.3&nbsp;&nbsp;&nbsp; Skin irritation, corrosion, sensitization

6.4&nbsp;&nbsp;&nbsp; Genotoxicity

6.5&nbsp;&nbsp;&nbsp; Cytotoxicity

6.6&nbsp;&nbsp;&nbsp; Ocular toxicity

6.7&nbsp;&nbsp;&nbsp; Organ toxicity

6.8&nbsp;&nbsp;&nbsp; Phototoxicity

6.9&nbsp;&nbsp;&nbsp; Dermal toxicity

6.10&nbsp;&nbsp;&nbsp; Other endpoints and tests

Chapter 7&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Technology, 2018 &ndash; 2032 ($ Mn)

7.1&nbsp;&nbsp;&nbsp; Key trends

7.2&nbsp;&nbsp;&nbsp; Cell culture

7.3&nbsp;&nbsp;&nbsp; High throughput

7.4&nbsp;&nbsp;&nbsp; Toxicogenomics

Chapter 8&nbsp; &nbsp;Market Estimates and Forecast, By Method, 2018 &ndash; 2032 ($ Mn)

9.1&nbsp;&nbsp;&nbsp; Key trends

9.2&nbsp;&nbsp;&nbsp; Cellular assays

9.3&nbsp;&nbsp;&nbsp; Biochemical assays

9.4&nbsp;&nbsp;&nbsp; In silico models

9.5&nbsp;&nbsp;&nbsp; Ex vivo models

Chapter 9&nbsp; &nbsp;Market Estimates and Forecast, By Industry, 2018 &ndash; 2032 ($ Mn)

8.1&nbsp;&nbsp;&nbsp; Key trends

8.2&nbsp;&nbsp;&nbsp; Pharmaceuticals and biopharmaceuticals

8.3&nbsp;&nbsp;&nbsp; Cosmetics and household products

8.4&nbsp;&nbsp;&nbsp; Food

8.5&nbsp;&nbsp;&nbsp; Chemicals

Chapter 10&nbsp;&nbsp;&nbsp;Market Estimates and Forecast, By Region, 2018 &ndash; 2032 ($ Mn)

10.1&nbsp;&nbsp;&nbsp; Key trends

10.2&nbsp;&nbsp;&nbsp; North America

10.2.1&nbsp;&nbsp;&nbsp; U.S.

10.2.2&nbsp;&nbsp;&nbsp; Canada

10.3&nbsp;&nbsp;&nbsp; Europe

10.3.1&nbsp;&nbsp;&nbsp; Germany

10.3.2&nbsp;&nbsp;&nbsp; UK

10.3.3&nbsp;&nbsp;&nbsp; France

10.3.4&nbsp;&nbsp;&nbsp; Spain

10.3.5&nbsp;&nbsp;&nbsp; Italy

10.3.6&nbsp;&nbsp;&nbsp; Rest of Europe

10.4&nbsp;&nbsp;&nbsp; Asia Pacific

10.4.1&nbsp;&nbsp;&nbsp; Japan

10.4.2&nbsp;&nbsp;&nbsp; China

10.4.3&nbsp;&nbsp;&nbsp; India

10.4.4&nbsp;&nbsp;&nbsp; Australia

10.4.5&nbsp;&nbsp;&nbsp; South Korea

10.4.6&nbsp;&nbsp;&nbsp; Rest of Asia Pacific

10.5&nbsp;&nbsp;&nbsp; Latin America

10.5.1&nbsp;&nbsp;&nbsp; Brazil

10.5.2&nbsp;&nbsp;&nbsp; Mexico

10.5.3&nbsp;&nbsp;&nbsp; Argentina

10.5.4&nbsp;&nbsp;&nbsp; Rest of Latin America

10.6&nbsp;&nbsp;&nbsp; Middle East and Africa

10.6.1&nbsp;&nbsp;&nbsp; South Africa

10.6.2&nbsp;&nbsp;&nbsp; Saudi Arabia

10.6.3&nbsp;&nbsp;&nbsp; UAE

10.6.4&nbsp;&nbsp;&nbsp; Rest of Middle East and Africa

Chapter 11&nbsp;&nbsp;&nbsp;Company Profiles

11.1&nbsp;&nbsp;&nbsp; Abbott Laboratories

11.2&nbsp;&nbsp;&nbsp; Agilent Technologies, Inc.

11.3&nbsp;&nbsp;&nbsp; Bio-Rad Laboratories, Inc.

11.4&nbsp;&nbsp;&nbsp; Catalent, Inc.

11.5&nbsp;&nbsp;&nbsp; Charles River Laboratories International, Inc.

11.6&nbsp;&nbsp;&nbsp; Danaher Corporation

11.7&nbsp;&nbsp;&nbsp; Eurofins Scientific

11.8&nbsp;&nbsp;&nbsp; Evotec S.E.

11.9&nbsp;&nbsp;&nbsp; Laboratory Corporation of America Holdings

11.10&nbsp;&nbsp;&nbsp; Merck KGaA

11.11&nbsp;&nbsp;&nbsp; Quest Diagnostics Incorporated

11.12&nbsp;&nbsp;&nbsp; SGS Societe&nbsp;Generale de Surveillance SA

11.13&nbsp;&nbsp;&nbsp; Thermo Fisher Scientific Inc. 
&nbsp;

Invitro Toxicology Testing Market

Get a free sample of this report